Ambrilia Biopharma Inc. (TSX: AMB), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today the appointment of Mr. Luc Tanguay, Senior Executive Vice-President and Chief Financial Officer of Theratechnologies Inc., to its Board of Directors.
